Generate a materia medica reference card for Symphytum Officinal
Reading File
Finding Sources
Searching the Web
Symphytum officinale materia medica homeopathy clinical indications keynotes
Searching PubMed
Symphytum officinale pharmacology clinical
Reading File
Reading File
Reading Web Page
Symphytum officinale pharmacology constituents indications toxicity dosage
I now have comprehensive information. Let me compile the full materia medica reference card.
Symphytum Officinale - Materia Medica Reference Card
Nomenclature & Taxonomy
| Field | Detail |
|---|---|
| Botanical Name | Symphytum officinale L. |
| Family | Boraginaceae |
| Common Names | Comfrey, Knitbone, Boneset, Bruisewort, Blackwort, Healing Herb, Slipper Root |
| Parts Used | Root (primary), leaves |
| Origin | Europe, Western Asia; naturalized globally |
| Preparation | Topical creams/ointments/gels, tinctures (historical internal use); homeopathic dilutions |
Key Bioactive Constituents
| Constituent | Class | Biological Role |
|---|---|---|
| Allantoin (0.6-0.8% in root) | Nitrogen heterocycle | Promotes cell proliferation, wound healing, epithelialization |
| Rosmarinic acid | Phenolic acid | Anti-inflammatory (inhibits NF-kB, MAPK pathways), antioxidant |
| Mucilage polysaccharides | Polysaccharide | Demulcent, soothing, promotes tissue repair |
| Pyrrolizidine alkaloids (PAs) | Alkaloids (toxic) | Intermedine, lycopsamine, symphytine - hepatotoxic metabolites |
| Triterpenes | Terpenoids | Anti-inflammatory |
| Tannins | Polyphenols | Astringent, antimicrobial |
| Choline | Quaternary amine | Cell membrane integrity |
| Allantoinic acid | Nitrogen heterocycle | Tissue regeneration support |
PA content is highest in the root and ranges from 0.02-0.07% (root) vs. lower in leaves. Topical absorption is 0.04-0.22% - considered minimal but cumulative oral exposure is dangerous.
Pharmacological Actions
Primary mechanisms:
- Inhibits NF-kB and MAPK signaling pathways, suppressing pro-inflammatory cytokines (IL-1beta, TNF-alpha, COX-2)
- Allantoin stimulates fibroblast proliferation and accelerates re-epithelialization
- Rosmarinic acid provides direct free-radical scavenging and inhibits lipoxygenase
- Polysaccharides form a protective demulcent film over mucous membranes and wounds
Demonstrated pharmacological activities:
- Anti-inflammatory
- Analgesic (peripheral)
- Bone and cartilage repair promotion
- Wound healing / tissue regeneration
- Mild astringent
- Antioxidant
Traditional & Ethnobotanical Uses (>2,000 years of use)
| System | Use |
|---|---|
| European traditional | Fractures, sprains, dislocations, bruises, wound healing |
| Gastrointestinal | Gastritis, peptic ulcers, irritable bowel (internal use - now contraindicated) |
| Respiratory | Pleurisy, bronchitis, hemoptysis (historical internal use) |
| Topical | Burns, eczema, psoriasis, varicose ulcers, phlebitis |
| Musculoskeletal | Arthritis, myalgia, back pain, tendonitis |
The name "knitbone" and the Greek root symphyo ("to unite") both reference the plant's traditional use in fracture healing.
Clinical Evidence (Modern Topical Use)
Evidence is specific to topical preparations - internal use is prohibited in most jurisdictions.
| Indication | Evidence Level | Finding |
|---|---|---|
| Acute low back pain | RCTs + multicenter trials | Significant pain reduction vs. placebo; non-inferior to diclofenac gel; rapid onset |
| Knee osteoarthritis | RCTs | Reduced pain and stiffness; non-inferior to diclofenac |
| Ankle sprains | RCTs | Improved pain, swelling, mobility vs. placebo |
| Myalgia | RCTs | Statistically significant pain relief |
| Wound healing | Preclinical + limited clinical | Allantoin promotes re-epithelialization |
- Tintinalli's Emergency Medicine lists Comfrey among herbal remedies whose traditional indications include "broken bones, wound healing, reduce joint inflammation"
- Katzung's Basic and Clinical Pharmacology (16th ed.) lists it under herbs requiring caution due to pyrrolizidine alkaloid content
Homeopathic Materia Medica (Symphytum)
(Following Allen's Keynotes tradition)
Sphere of action: Bones, periosteum, cartilage, tendons, eye.
Key Indications (Homeopathic):
- Fractures - promotes union of bones; periosteal irritation after fractures; "knitbone" in all potencies
- Eye injuries - blunt trauma to the globe ("black eye," contusion of eyeball); pain in the eye after a blow
- Pricking pain in old ulcers at the site of healed injuries
- Nonunion of fractures or slow healing bone
- Phantom limb pain following amputation (pain in amputated limbs)
- Irritability at fracture site long after apparent healing
- Exostoses - bony overgrowths
Characteristic modalities:
- Worse: Injury, touch over fracture site, motion of injured part
- Better: Rest, warmth (variable)
Characteristic symptoms:
- Pricking, stitching pain in bones
- Eye pain from blunt trauma is a keynote; the eyeball itself feels bruised
- Poorly healing fractures with persistent periosteal sensitivity
Relations:
- Compare: Arnica (trauma, bruising), Calcarea phosphorica (slow-healing fractures), Ruta graveolens (periosteal/tendon injury), Calendula (wound healing), Bryonia (bone/joint pain worse motion)
- Follows well: Arnica in acute trauma
- Complementary: Calc. phos.
Potencies used: 3X, 6X, 30C, 200C (clinical use); Mother Tincture for local application
Toxicology & Safety
| Route | Risk Level | Notes |
|---|---|---|
| Oral (ingestion) | HIGH - Contraindicated | Pyrrolizidine alkaloids cause hepatic veno-occlusive disease, liver fibrosis, cirrhosis, and potential hepatocellular carcinoma |
| Topical | LOW | Systemic PA absorption 0.04-0.22%; no serious adverse events in clinical trials |
| Topical >4-6 weeks | LOW-MODERATE | Avoid prolonged use on broken/open skin; absorption may increase |
Mechanism of PA hepatotoxicity:
PA alkaloids (intermedine, lycopsamine, symphytine) undergo CYP3A-mediated bioactivation in the liver to form reactive pyrrole intermediates that bind irreversibly to DNA and proteins, causing:
- Hepatocellular necrosis
- Sinusoidal endothelial injury
- Veno-occlusive disease (sinusoidal obstruction syndrome)
- DNA adduct formation -> genotoxicity and carcinogenicity
Tintinalli's Emergency Medicine and Katzung's Basic and Clinical Pharmacology (16th ed.) both classify comfrey as a hepatotoxic herbal remedy causing veno-occlusive disease.
Regulatory Status
| Region | Status |
|---|---|
| USA (FDA) | Internal use products voluntarily withdrawn from market; topical use not regulated as drug unless claiming disease treatment |
| Germany (Commission E) | Topical preparations approved for musculoskeletal conditions; internal use prohibited |
| EU | Topical use permitted with PA content limits (max 100 mcg/day); oral use prohibited |
| UK | Topical use permitted for licensed indications; internal use banned |
| Australia (TGA) | External use only; PA content limits apply |
Dosing (Topical Only - Evidence-Based)
| Form | Dose | Duration |
|---|---|---|
| Cream/Ointment (35% extract, PA-depleted) | Apply to affected area 3x daily | Maximum 4-6 weeks per course |
| Gel (standardized) | Apply thinly 2-3x daily | Maximum 4-6 weeks |
| Avoid: | Application to broken or ulcerated skin, near eyes, in children <12 years, during pregnancy/lactation |
Contraindications & Precautions
- Internal use (oral, rectal, injectable): Absolutely contraindicated due to PA hepatotoxicity
- Pregnancy and lactation: Contraindicated even topically (PA transfer risk)
- Open wounds and broken skin: Avoid (enhanced systemic PA absorption)
- Children under 12: Avoid topical use
- Hepatic disease: Avoid all forms
- Prolonged topical use: Limit to 4-6 weeks per session
Drug Interactions
| Interaction | Mechanism | Clinical Relevance |
|---|---|---|
| Hepatotoxic drugs (statins, azole antifungals, acetaminophen) | Additive liver toxicity | Avoid concurrent oral use |
| CYP3A4 inhibitors | May slow PA detoxification -> accumulation | Theoretical for oral exposure |
Summary Mnemonic: KNITBONE
- Knitting of fractures - primary traditional use
- Non-union and periosteal pain - homeopathic keynote
- Inflammation - topical anti-inflammatory (rosmarinic acid, allantoin)
- Topical only - oral use is hepatotoxic
- Bonemeal-type pain; blunt eye trauma (homeopathic)
- Ointments - evidence-based for back pain, OA, sprains
- NF-kB inhibition - molecular mechanism
- Exostoses and phantom pain - homeopathic sphere
Sources: Tintinalli's Emergency Medicine (9th ed.), Katzung's Basic and Clinical Pharmacology (16th ed.), Sleisenger & Fordtran's Gastrointestinal and Liver Disease, Allen's Materia Medica Keynotes; PMC13079377 (ethnopharmacological review, 2025)
Clinical Note: Symphytum's reputation as a bone and tissue healer has genuine biochemical backing (allantoin, rosmarinic acid), and modern RCTs support its topical use for musculoskeletal pain. However, internal use carries a well-documented risk of irreversible hepatic veno-occlusive disease and is prohibited in most countries. All therapeutic use should be confined to PA-depleted topical formulations, limited to 4-6 weeks duration.
This is a shared conversation. Sign in to Orris to start your own chat.